There have been a number of reports concerning the use of sulfapyridine in the treatment of pneumonia in infancy and childhood during the past few months.1 A review of the literature will not be made here. The present series of ninety-three cases is reported because of the successful results in lobar (pneumococcus) pneumonia from the use of the drug in small doses and for a short time.
These patients were treated with sulfapyridine in the Children's Medical Service of Bellevue Hospital between January and July 1939. All patients under 12 years of age having pneumonia had a bacteriologic study with cultures from the throat by the technic described2 for pneumococcus typing and blood agar plates for streptococcus study in many cases (table 1). No attempt was made to have a control series, since the early results made it seem unfair to withhold the drug from sick children. Our
SMITH CH, NEMIR RL. THE SULFAPYRIDINE TREATMENT OF PNEUMONIA IN CHILDREN. JAMA. 1939;113(21):1857–1860. doi:10.1001/jama.1939.02800460011003
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: